Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations

被引:40
作者
Christenson, RH
Cervelli, DR
Bauer, RS
Gordon, M
机构
[1] Univ Maryland, Med Ctr, Pathol Lab, Dept Pathol,Sch Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med & Res Technol, Baltimore, MD 21201 USA
[3] Dade Behring Inc, Newark, DE 19702 USA
关键词
Stratus((R)) CS; imprecision; concentration;
D O I
10.1016/j.clinbiochem.2004.03.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Define performance characteristics of the Stratus(R) CS cardiac troponin I (cTnI) assay in routine practice. Methods: Imprecision at low cTnI values was assessed according to NCCLS EP5-A. Linearity was assessed by regression analysis; the reference interval was determined in 345 healthy individuals. Minimum detectable concentration (MDC) was assessed with 20 replicates of zero calibrator, and method correlation and bias (n = 77) were by Passing-Bablok regression and Bland-Altman plot. Results: cTnI of 0.06 mug/l corresponded to the 10% CV; the 99th percentile of the reference population was 0.07 mug/l. Linearity extended from 0 to 50.0 mug/l and the MDC was 0.010 mug/l. The method comparison equation was Stratus(R) CS = 1.00 (Dimension(R) RxL)-0.02 mug/l with no bias. Conclusions: The Stratus(R) CS cTnI assay in routine practice has performance characteristics appropriate for clinical use, including good correlation to a central laboratory cTnI method and imprecision of a high sensitivity troponin method with a CV of <10% at the 99th percentile of the reference population. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:679 / 683
页数:5
相关论文
共 11 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]  
Altinier S, 2000, CLIN CHEM, V46, P991
[3]  
*AM HEART ASS, 2001, HEART STROK STAT UPD
[4]  
Christenson RH, 2001, CLIN CHEM, V47, P431
[5]  
Heeschen C, 1999, CLIN CHEM, V45, P1789
[6]  
KAUL P, IN PRESS J AM COLL C
[7]  
Kim WJ, 2002, CLIN CHEM, V48, P1028
[8]   Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction - Results from a randomized trial [J].
Morrow, DA ;
Cannon, CP ;
Rifai, N ;
Frey, MJ ;
Vicari, R ;
Lakkis, N ;
Robertson, DH ;
Hille, DA ;
DeLucca, PT ;
DiBattiste, PM ;
Demopoulos, LA ;
Weintraub, WS ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19) :2405-2412
[9]  
Morrow DA, 2000, CLIN CHEM, V46, P453
[10]   Evaluation of imprecision for cardiac troponin assays at low-range concentrations [J].
Panteghini, M ;
Pagani, F ;
Yeo, KTJ ;
Apple, FS ;
Christenson, RH ;
Dati, F ;
Mair, J ;
Ravkilde, J ;
Wu, AHB .
CLINICAL CHEMISTRY, 2004, 50 (02) :327-332